NEW YORK (Reuters Health) – Long-term glucocorticoid (GC) users see greater gains in spine bone-mineral density when treated with the monoclonal antibody denosumab versus oral
Read more
Home ยป
NEW YORK (Reuters Health) – Long-term glucocorticoid (GC) users see greater gains in spine bone-mineral density when treated with the monoclonal antibody denosumab versus oral
Read moreAlmost 1 in 4 men and women diagnosed with kidney stones have osteoporosis or a history of fracture at the time of their diagnosis, yet
Read more(Reuters Health) – Daily relugolix therapy cuts menstrual bleeding by at least half without affecting bone density in 71% of women with uterine fibroids, according
Read more